MARZO 2023
Uremia durante la injuria renal aguda
David González-Barajas y Jonathan S. Chávez-Íñiguez
Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco. Mexico. University of Guadalajara Health Sciences Center, Guadalajara, Jalisco. Mexico
Tabla. Estudios que han considerado niveles sericos de urea en sangre como criterios de TRR
| Estudio | Año | Urea sérica considerada para inicio de TRR |
|---|---|---|
| Zarbock y otros. [9] | 2016 | Urea sérica >100 mg/dL (35.7 mmol/L) |
| Gaudry y otros. [8] | 2016 | Urea sérica >112 mg/dL (40 mmol/L) |
| Combes y otros. | 2015 | Urea sérica >36 mmol/L |
| Jamale y otros. | 2013 | Náusea urémica |
| Bagshaw y otros | 2009 | Urea sérica >24.2 mmol/L |
| Boulman y otros. | 2002 | Urea sérica >40 mmol/L |
| Pursnani y otros. | 1997 | Urea sérica >40 mmol/L |
Referencias
1. Almeras C, Argilés A. The general picture of uremia. Semin Dial. 2009 Jul-Aug;22(4):329-33. doi: 10.1111/j.1525-139X.2009.00575.x. PMID: 19708976.
2. Vanholder R, Gryp T, Glorieux G. Urea and chronic kidney disease: the comeback of the century? (in uraemia research). Nephrol Dial Transplant. 2018 Jan 1;33(1):4-12. doi: 10.1093/ndt/gfx039. PMID: 28407121.
3. do Nascimento, G. V., Balbi, A. L., Ponce, D., & Abrão, J. M. (2012). Early initiation of dialysis: mortality and renal function recovery in acute kidney injury patients. Jornal brasileiro de nefrologia : ‘orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia, 34(4), 337–342. https://doi.org/10.5935/0101-2800.20120022
4. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. Erratum in: J Am Soc Nephrol. 2013 Dec;24(12):2127-9. PMID: 22626821; PMCID: PMC3380651.
5. Mackenzie J, Chacko B. An isolated elevation in blood urea level is not ‘uraemia’ and not an indication for renal replacement therapy in the ICU. Crit Care. 2017 Nov 13;21(1):275. doi: 10.1186/s13054-017-1868-x. PMID: 29132411; PMCID: PMC5683443.
6. Verdier V, Soulage CO, Koppe L. New clinical evidence for urea toxicity. Nephrol Dial Transplant. 2021 Dec 31;37(1):1-4. doi: 10.1093/ndt/gfab269. PMID: 34519782.
7. Gibney N, Hoste E, Burdmann EA, Bunchman T, Kher V, Viswanathan R, Mehta RL, Ronco C. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol. 2008 May;3(3):876-80. doi: 10.2215/CJN.04871107. Epub 2008 Mar 5. PMID: 18322044.
8. Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, Titeca-Beauport D, Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Bohé J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Rozec B, Cadoz C, Andreu P, Reignier J, Ricard JD, Quenot JP, Dreyfuss D. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021 Apr 3;397(10281):1293-1300. doi: 10.1016/S0140-6736(21)00350-0. PMID: 33812488.
9. Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA. 2016;315:2190.
10. Kellum J.A., Lameire N., Aspelin P., Barsoum R.S., Burdmann E.A., Goldstein S.L., Herzog C.A., (…), Uchino S. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury (2012) Kidney International Supplements, 2 (1), pp. 1-138.
11. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. Rev Esp Salud Publica. 2008;82(3):251-9.
12. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Workgroup. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2:1–138.
13. Chugh S, Singh J, Kichloo A, Gupta S, Katchi T, Solanki S. Uremic- and Dialysis-Associated Pericarditis. Cardiol Rev. 2021 Nov-Dec 01;29(6):310-313. doi: 10.1097/CRD.0000000000000381. PMID: 33337656.
14. Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011 Apr;31(2):139-43. doi: 10.1055/s-0031-1277984. Epub 2011 May 17. PMID: 21590619.
15. Rydzewska-Rosołowska A, Sroka N, Kakareko K, Rosołowski M, Zbroch E, Hryszko T. The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut FeelingA Systematic Review. Toxins (Basel). 2020 Dec 11;12(12):788. doi: 10.3390/toxins12120788. PMID: 33322362; PMCID: PMC7764335.
16. Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009 May-Jun;22(3):279-86. doi: 10.1111/j.1525-139X.2008.00556.x. PMID: 19573008.
17. Gunst J, Kashani KB, Hermans G. The urea-creatinine ratio as a novel biomarker of critical illness-associated catabolism. Intensive Care Med. 2019 Dec;45(12):1813-1815. doi: 10.1007/s00134-019-05810-y. Epub 2019 Oct 16. PMID: 31620835.
18. Gabriel DP, Caramori JT, Martim LC, Barretti P, Balbi AL. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl. 2008 Apr;(108):S87-93. doi: 10.1038/sj.ki.5002608. PMID: 18379555.
19. Ponce D, Berbel MN, Abrão JM, Goes CR, Balbi AL. A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol. 2013 Jun;45(3):869-78. doi: 10.1007/s11255-012-0301-2. Epub 2012 Oct 12. PMID: 23065432.
20. Chávez-Iñiguez JS, Navarro-Gallardo GJ, Medina-González R, Alcantar-Vallin L, GarcíaGarcía G. Acute Kidney Injury Caused by Obstructive Nephropathy. Int J Nephrol. 2020 Nov 29;2020:8846622. doi: 10.1155/2020/8846622. PMID: 33312728; PMCID: PMC7719507.
21. Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettilä V, Prowle JR, Schetz M, Joannidis M. Renal recovery after acute kidney injury. Intensive Care Med. 2017 Jun;43(6):855-866. doi: 10.1007/s00134-017-4809-x. Epub 2017 May 2. PMID: 28466146; PMCID: PMC5487594.
22. Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G. Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999 Jan;33(1):142-9. doi: 10.1016/s0272-6386(99)70272-6. PMID: 9915282.
23. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002 May;13(5):1307-1320. doi: 10.1681/ASN.V1351307. PMID: 11961019.
24. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93. PMID: 21091062; PMCID: PMC3042140